VSIR and breast cancer: Unlike what was observed for Dies1 in breast cancer cell lines, ID2 and ID3 were significantly downregulated in all cell lines (p < 2.72E-03), demonstrating no relationship between Dies1 and its potential downstream targets ID2 and ID3 in this cancer type.